AAAAAA

   
Results: 1-10 |
Results: 10
A PHASE-I STUDY OF TLC D-99 (LIPOSOME-ENCAPSULATED DOXORUBICIN) WITH G-CSF IN PATIENTS WITH REFRACTORY SOLID TUMORS
Authors: ELIAS A HOOFTMAN L MAZANET R ODAY S LEE L AZARNIA N
Citation: A. Elias et al., A PHASE-I STUDY OF TLC D-99 (LIPOSOME-ENCAPSULATED DOXORUBICIN) WITH G-CSF IN PATIENTS WITH REFRACTORY SOLID TUMORS, Annals of oncology, 9, 1998, pp. 631-631
PHASE-I STUDY OF HIGH-DOSE IFOSFAMIDE, CARBOPLATIN AND ETOPOSIDE WITHAUTOLOGOUS HEMATOPOIETIC STEM-CELL SUPPORT
Authors: ELIAS AD AYASH LJ WHEELER C SCHWARTZ G TEPLER I GONIN R MCCAULEY M MAZANET R SCHNIPPER L FREI E ANTMAN KH
Citation: Ad. Elias et al., PHASE-I STUDY OF HIGH-DOSE IFOSFAMIDE, CARBOPLATIN AND ETOPOSIDE WITHAUTOLOGOUS HEMATOPOIETIC STEM-CELL SUPPORT, Bone marrow transplantation, 15(3), 1995, pp. 373-379
THE COLLECTION AND EVALUATION OF PERIPHERAL-BLOOD PROGENITOR CELLS SUFFICIENT FOR REPETITIVE CYCLES OF HIGH-DOSE CHEMOTHERAPY SUPPORT
Authors: BENJAMIN RJ LINSLEY L AXELROD JD CHURCHILL WH SIEFF C SHULMAN LN ELIAS A AYASH L MALACHOWSKI ME UHL L GAYNES L MCCAULEY M THOMPSON L MAZANET R ANTMAN K SCHNIPPER L TEPLER I ANTIN JH WHEELER C
Citation: Rj. Benjamin et al., THE COLLECTION AND EVALUATION OF PERIPHERAL-BLOOD PROGENITOR CELLS SUFFICIENT FOR REPETITIVE CYCLES OF HIGH-DOSE CHEMOTHERAPY SUPPORT, Transfusion, 35(10), 1995, pp. 837-844
PHASE-IV TRIAL OF DAILY ORAL ETOPOSIDE IN THE TREATMENT OF ADVANCED SOFT-TISSUE SARCOMA
Authors: LICHT JD MAZANET R LOEHRER PJ GONIN R ANTMAN KH
Citation: Jd. Licht et al., PHASE-IV TRIAL OF DAILY ORAL ETOPOSIDE IN THE TREATMENT OF ADVANCED SOFT-TISSUE SARCOMA, Cancer chemotherapy and pharmacology, 34(1), 1994, pp. 79-80
HIGH-DOSE IFOSFAMIDE CARBOPLATIN/ETOPOSIDE WITH AUTOLOGOUS HEMATOPOIETIC STEM-CELL SUPPORT - SAFETY AND FUTURE-DIRECTIONS/
Authors: ELIAS AD AYASH LJ WHEELER C SCHWARTZ G TEPLER I MCCAULEY M MAZANET R SCHNIPPER L FREI E ANTMAN KH
Citation: Ad. Elias et al., HIGH-DOSE IFOSFAMIDE CARBOPLATIN/ETOPOSIDE WITH AUTOLOGOUS HEMATOPOIETIC STEM-CELL SUPPORT - SAFETY AND FUTURE-DIRECTIONS/, Seminars in oncology, 21(5), 1994, pp. 83-85
RECOMBINANT-HUMAN-ERYTHROPOIETIN FOR THE TREATMENT OF THE ANEMIA ASSOCIATED WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION
Authors: AYASH LJ ELIAS A HUNT M DEMETRI G WHEELER C TEPLER I SCHWARTZ G MAZANET R REICH E MCCAULEY M ANTMAN K ANDERSON KC
Citation: Lj. Ayash et al., RECOMBINANT-HUMAN-ERYTHROPOIETIN FOR THE TREATMENT OF THE ANEMIA ASSOCIATED WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION, British Journal of Haematology, 87(1), 1994, pp. 153-161
STRATEGIES FOR MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS FOR USE INHIGH-DOSE CHEMOTHERAPY
Authors: WEBB IJ AYASH LJ EICKHOFF CE WHEELER C SCHWARTZ G MAZANET R DEMETRI G ANTMAN K SCHNIPPER L FREI E ELIAS A
Citation: Ij. Webb et al., STRATEGIES FOR MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS FOR USE INHIGH-DOSE CHEMOTHERAPY, Blood, 84(10), 1994, pp. 10000105-10000105
USE OF PERIPHERAL-BLOOD PROGENITOR CELLS ABROGATES THE MYELOTOXICITY OF REPETITIVE OUTPATIENT HIGH-DOSE CARBOPLATIN AND CYCLOPHOSPHAMIDE CHEMOTHERAPY
Authors: TEPLER I CANNISTRA SA FREI E GONIN R ANDERSON KC DEMETRI G NILOFF J GOODMAN H MUNTZ H MUTO M SHEETS E ELIAS AD MAZANET R WHEELER C AYASH L SCHWARTZ G MCCAULEY M GAYNES L HARVEY S SCHNIPPER LE ANTMAN KH
Citation: I. Tepler et al., USE OF PERIPHERAL-BLOOD PROGENITOR CELLS ABROGATES THE MYELOTOXICITY OF REPETITIVE OUTPATIENT HIGH-DOSE CARBOPLATIN AND CYCLOPHOSPHAMIDE CHEMOTHERAPY, Journal of clinical oncology, 11(8), 1993, pp. 1583-1591
PROGNOSTIC FACTORS FOR TREATMENT OUTCOME IN AUTOTRANSPLANTATION OF INTERMEDIATE-GRADE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA WITH CYCLOPHOSPHAMIDE, CARMUSTINE, AND ETOPOSIDE
Authors: WHEELER C STRAWDERMAN M AYASH L CHURCHILL WH BIERER BE ELIAS A GILLILAND DG ANTMAN K GUINAN EC EDER JP WEINSTEIN H SCHWARTZ G FERRARA J MAZANET R RIMM IJ TEPLER I MCCARTHY P MAUCH P AULT K GAYNES L MCCAULEY M SCHNIPPER LE ANTIN J
Citation: C. Wheeler et al., PROGNOSTIC FACTORS FOR TREATMENT OUTCOME IN AUTOTRANSPLANTATION OF INTERMEDIATE-GRADE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA WITH CYCLOPHOSPHAMIDE, CARMUSTINE, AND ETOPOSIDE, Journal of clinical oncology, 11(6), 1993, pp. 1085-1091
SEQUENTIAL IFOSFAMIDE (I), CARBOPLATIN (C), AND ETOPOSIDE (E) WITH STEROIDS AND CYCLOPHOSPHAMIDE G-CSF MOBILIZED PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) SUPPORT (SPICE) IN RELAPSED LYMPHOMA/
Authors: WHEELER C SHULMAN LN ELIAS A AXELROD J SIEFF C CHURCHILL WH AYASH L GAYNES L MCCAULEY M THOMPSON L MAZANET R ANTMAN K TEPLER I SCHNIPPER L WEGNER S SCHWARTZ G ANTIN JH
Citation: C. Wheeler et al., SEQUENTIAL IFOSFAMIDE (I), CARBOPLATIN (C), AND ETOPOSIDE (E) WITH STEROIDS AND CYCLOPHOSPHAMIDE G-CSF MOBILIZED PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) SUPPORT (SPICE) IN RELAPSED LYMPHOMA/, Blood, 82(10), 1993, pp. 10000144-10000144
Risultati: 1-10 |